AI Portfolio Summary
In 2025 Q4, BML Capital Management, LLC maintained a portfolio of 24 distinct positions. The most significant new addition to the portfolio was CARMAX INC, which now represents 5.18% of the total fund value. They heavily accumulated shares in ATEA PHARMACEUTICALS, increasing their position by 0.2%. Conversely, BML Capital Management, LLC completely exited their position in ADVERUM BIOTECHNOLOG.
Total Positions
24
Quarter
2025 Q4
Top Holding
ACRS (37.1%)
Top 10 Concentration
95.6%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-24 of 24
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ACRS
ACLARIS THERAPE...
|
Healthcare | 37.08% | 24.79% |
#1
Prev: #1
|
10.0 | no change | no change |
P
S
|
14,250,000 | $42,892,500 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AVIR
ATEA PHARMACEUT...
|
Healthcare | 23.11% | 19.85% |
#2
Prev: #2
|
10.0 | 16,037 | 0.2% |
P
S
|
7,490,000 | $26,739,300 | 2023 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ORMP
ORAMED PHARMACE...
|
Healthcare | 7.80% | 7.66% |
#3
2
Prev: #5
|
3.1 | no change | no change |
P
S
|
3,167,231 | $9,026,608 | 2023 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TIL
INSTIL BIO INC
|
Healthcare | 6.14% | 10.56% |
#4
Prev: #4
|
2.5 | no change | no change |
P
S
|
645,600 | $7,101,600 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PMVP
PMV PHARMACEUTI...
|
Healthcare | 5.72% | 6.78% |
#5
1
Prev: #6
|
2.3 | no change | no change |
P
S
|
5,292,000 | $6,615,000 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
KMX
CARMAX INC
|
Consumer Cyclical | 5.18% | — |
#6
Prev: #—
|
4.1 | 155,000 | no change |
NEW
|
155,000 | $5,989,200 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
KZR
KEZAR LIFE SCIE...
|
Healthcare | 3.92% | 2.57% |
#7
2
Prev: #9
|
1.6 | no change | no change |
P
S
|
720,787 | $4,533,750 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TGT
TARGET CORP
|
Consumer Defensive | 3.17% | 0.82% |
#8
6
Prev: #14
|
3.6 | 27,500 | 275.0% |
P
S
|
37,500 | $3,665,625 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CVNA
PUT
CARVANA CO
|
PUT Option | 1.74% | — |
#9
Prev: #—
|
2.7 | 150 | no change |
NEW
|
150 | $2,016,000 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
OM
OUTSET MED INC
|
Healthcare | 1.74% | — |
#10
Prev: #—
|
2.7 | 543,180 | no change |
NEW
|
543,180 | $2,015,198 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PLRX
PLIANT THERAPEU...
|
Healthcare | 1.63% | — |
#11
Prev: #—
|
2.7 | 1,546,137 | no change |
NEW
|
1,546,137 | $1,886,287 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IMA
IMAGENEBIO INC
|
Healthcare | 1.06% | 1.36% |
#12
1
Prev: #11
|
0.4 | -5,483 | -3.0% |
P
S
|
177,026 | $1,221,479 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
N/A
CONNECT BIOPHAR...
|
—
|
Unknown | 1.00% | 1.75% |
#13
3
Prev: #10
|
0.6 | -858,613 | -67.7% |
P
S
|
408,887 | $1,153,061 | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
WMT
PUT
WALMART INC
|
PUT Option | 0.43% | 0.47% |
#14
2
Prev: #16
|
2.2 | 70 | 26.4% |
P
S
|
335 | $492,450 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TSLA
PUT
TESLA INC
|
PUT Option | 0.18% | — |
#15
Prev: #—
|
2.1 | 1,000 | no change |
NEW
|
1,000 | $205,000 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LSTA
LISATA THERAPEU...
|
Healthcare | 0.12% | 0.26% |
#16
2
Prev: #18
|
0.1 | -36,493 | -33.2% |
P
S
|
73,348 | $136,427 | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ADVM
ADVERUM BIOTECH...
|
Healthcare | 0.00% | 12.68% |
Sold All 😨
(Was: #3) |
0.3 | -3,057,526 | -100.0% |
CLOSED
|
— | $— | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ALMS
ALUMIS INC
|
Healthcare | 0.00% | 4.42% |
Sold All 😨
(Was: #7) |
0.3 | -1,210,415 | -100.0% |
CLOSED
|
— | $— | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LVTX
LAVA THERAPEUTI...
|
Unknown | 0.00% | 2.81% |
Sold All 😨
(Was: #8) |
0.3 | -1,970,610 | -100.0% |
CLOSED
|
— | $— | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LONA
ATHIRA PHARMA I...
|
Healthcare | 0.00% | 1.22% |
Sold All 😨
(Was: #12) |
0.3 | -323,066 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ASTC
ASTROTECH CORP
|
Technology | 0.00% | 0.99% |
Sold All 😨
(Was: #13) |
0.3 | -220,410 | -100.0% |
CLOSED
|
— | $— | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VTGN
VISTAGEN THERAP...
|
Healthcare | 0.00% | 0.49% |
Sold All 😨
(Was: #15) |
0.3 | -150,000 | -100.0% |
CLOSED
|
— | $— | 2023 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ARVN
ARVINAS INC
|
Healthcare | 0.00% | 0.39% |
Sold All 😨
(Was: #17) |
0.3 | -50,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MURA
MURAL ONCOLOGY ...
|
Healthcare | 0.00% | 0.11% |
Sold All 😨
(Was: #19) |
0.3 | -57,500 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-24 of 24 holdings